0:000:00
<p>The big beta-blocker story from ESC, dual pathway therapy with aspirin and OAC, stopping OAC after successful AF ablation, and DANCAVAS II trial are the topics John Mandrola, MD, discusses on this week's podcast.</p> <p><em>This podcast is intended for healthcare professionals only</em>.</p> <p>To read a partial transcript or to comment, visit:</p> <p>https://www.medscape.com/twic</p> <p><strong>I Listener Feedback</strong></p> <p><strong>This Week in Cardiology Podcast – August 29 https://www.medscape.com/viewarticle/1002877</strong></p> <p><strong>II The Big Beta-blocker Story from ESC</strong></p> <p><strong>Beta-Blockers Post-MI: A Clear Clinical Message https://www.medscape.com/viewarticle/beta-blockers-post-mi-clear-clinical-message-2025a1000mz0</strong></p> <ul> <li><strong>REBOOT https://www.nejm.org/doi/full/10.1056/NEJMoa2504735</strong></li> <li><strong>BETAMI-DANBLOCK https://www.nejm.org/doi/abs/10.1056/NEJMoa2505985</strong></li> </ul> <ul> <li><strong>REDUCE AMI https...